PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
基本信息
- 批准号:10264785
- 负责人:
- 金额:$ 46.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-16 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:African AmericanAgeBenignBiologicalBiological AssayBiological ClocksBiologyBreastCatalytic RNACell AgingCell SurvivalCellsChromosomal StabilityChromosomesClinicCodeComplexDNADNA SequenceDataDiagnosticDiseaseElectronic Health RecordEnvironmental Risk FactorEtiologyFutureGenesGeneticGenetic Predisposition to DiseaseGenomeGenomicsGenotypeGliomaGoalsHealthHealthcare SystemsHumanIndividualInternational Classification of Disease CodesKnowledgeLengthLinkMalignant NeoplasmsMeasuresMedicalMendelian randomizationMethodological StudiesPancreasParticipantPatientsPhenotypePlayPopulationPopulation HeterogeneityProcessPropertyProstateRiskRoleSamplingTelomeraseTestingTimeTranscendVariantbead chipbiobankclinically significantethnic diversityexomeexperimental studyfollow-upfunctional genomicsgenetic variantgenome integritygenome wide association studygenome-widegenomic biomarkergenomic datahuman diseaseillness lengthinnovationinsightlifetime risknovelpersonalized medicinephenomephenotypic dataracial diversitytelomeretraittumortumorigenesiswhole genome
项目摘要
ABSTRACT:
Human diseases are influenced by complex interactions between genetic and environmental factors.
Identifying genomic biomarkers that can transcend these complexities would be of great importance.
Telomeres are repetitive DNA sequences that cap the ends of chromosomes. They are necessary for
maintaining chromosomal stability and play an important role in cell viability. As humans age, telomeres
become shorter with every cellular division thus providing the cell with an internal biological clock for
viability. When telomeres become excessively short, the cell enters replicative senescence.
Dysregulation of telomeres is common in many cancers, and variability in telomere length (TL) is known
to be associated with many diseases. Genome-wide association studies (GWASs) have also identified
approximately 30 candidate variants that influence normal variation in TL, and some of these variants
have been linked to human disease. It is hypothesized that TL, and variants that are associated with
TL, may provide diagnostic and predictive information for many diseases. To test this hypothesis, we
propose the following aims: (1) associate thousands of clinically significant phenotypes with TL by
phenome-wide association studies (PheWAS), (2) conduct the largest single GWAS of TL to identify
novel variants associated with the trait, and (3) identify diseases that are associated with genetic
variants that influence TL by PheWAS. To accomplish these aims, this study will leverage 70,000
ethnically diverse DNA samples from two large healthcare systems. All DNA samples are linked to
genomic data and long-term electronic health records. Through the proposed GWAS and PheWAS
experiments, we expect to gain knowledge concerning the importance of telomere biology in human
health and its diagnostic utility for various diseases.
摘要:
人类疾病受到遗传和环境因素之间复杂相互作用的影响。
确定能够超越这些复杂性的基因组生物标志物将非常重要。
端粒是覆盖染色体末端的重复DNA序列。它们是必要的
维持染色体稳定性,并在细胞活力中发挥重要作用。随着人类年龄的增长,
随着每次细胞分裂而变短,从而为细胞提供内部生物钟,
生存能力。当端粒变得过短时,细胞进入复制性衰老。
端粒的失调在许多癌症中是常见的,并且端粒长度(TL)的可变性是已知的
与许多疾病有关。全基因组关联研究(GWAS)也发现了
大约30个候选变异影响TL的正常变异,其中一些变异
与人类疾病有关。据推测,TL和与之相关的变体
TL可以为许多疾病提供诊断和预测信息。为了验证这个假设,我们
提出以下目标:(1)通过以下方法将数千种临床显著表型与TL相关联:
全表型关联研究(PheWAS),(2)进行TL的最大单个GWAS,以确定
与该特征相关的新变体,以及(3)识别与遗传相关的疾病
通过PheWAS影响TL的变体。为了实现这些目标,这项研究将利用70,000
来自两个大型医疗系统的不同种族的DNA样本所有的DNA样本都与
基因组数据和长期电子健康记录。通过拟议的GWAS和PheWAS
通过这些实验,我们期望获得关于端粒生物学在人类中的重要性的知识。
健康及其对各种疾病的诊断效用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott Joseph Hebbring其他文献
Scott Joseph Hebbring的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott Joseph Hebbring', 18)}}的其他基金
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
10458116 - 财政年份:2020
- 资助金额:
$ 46.72万 - 项目类别:
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
10664860 - 财政年份:2020
- 资助金额:
$ 46.72万 - 项目类别:
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
9886470 - 财政年份:2020
- 资助金额:
$ 46.72万 - 项目类别:
Development and Application of Phenome-wide Scan of Heritability (PheSH)
全表型组遗传力扫描(PheSH)的开发和应用
- 批准号:
8679493 - 财政年份:2014
- 资助金额:
$ 46.72万 - 项目类别:
Development and Application of Phenome-wide Scan of Heritability (PheSH)
全表型组遗传力扫描(PheSH)的开发和应用
- 批准号:
8853944 - 财政年份:2014
- 资助金额:
$ 46.72万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 46.72万 - 项目类别:
Research Grant